Icagen to Present at the Antiepileptic Drug Trials XI Conference
April 19, 2011 08:00 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 19, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that management will participate in the Antiepileptic Drug Trials XI Conference to be held...
Icagen Reports Fourth Quarter and Full Year 2010 Financial Results and Operational Highlights
March 07, 2011 08:00 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 7, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the fourth quarter and full year ended...
Icagen to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on March 7, 2011
February 23, 2011 08:00 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced it will release financial results for the fourth quarter and full year 2010 on Monday, March...
Icagen to Present at the 13th Annual BIO CEO & Investor Conference on February 15, 2011
February 03, 2011 08:30 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 3, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the 13th Annual BIO CEO and Investor Conference...
Icagen Announces Lifting of Clinical Hold of ICA-105665
February 02, 2011 08:15 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 2, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that, following a review of data from recently completed clinical studies as well as the...
Icagen Announces Management Changes
December 20, 2010 16:50 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 20, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that Seth V. Hetherington, M.D., SVP, Clinical and Regulatory Affairs, will be leaving the...
Icagen and Pfizer Initiate Phase I Trial in Nav1.7 Program
December 20, 2010 08:00 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 20, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today provided an update on its sodium channel program for pain and related disorders, which is being...
Icagen and Pfizer Select Compound for Advancement in Nav1.7 Program
November 30, 2010 08:30 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today provided an update on its sodium channel program for pain and related disorders which is being...
Icagen Reports Third Quarter 2010 Financial Results and Operational Highlights
November 09, 2010 08:30 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 9, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the third quarter ended September 30,...
Icagen Announces Receipt of Three Federal Government Grants
November 02, 2010 08:30 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 2, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that it has been awarded approximately $733,000 of federal government grants under the...